Biomarker Menu
Biomarker Menu

Explore Our Biomarker Menu

Including 400+ Biomarker Offerings for a Range of Disease States

Return to Biomarker Menu

Biomarker: M65 (Keratin18)

Search for Biomarkers

Analyte:

M65 (Keratin18)

Platform:

Matrix:

Human K2 EDTA Plasma

Disease State:

Status:

Validated

Required Sample Volume:

25 µL/well

Sensitivity-LLOQ/ULOQ:

LLOQ: 250 U/L
ULOQ: 4,000 U/L

Biological or Clinical Significance:

The M65® ELISA measures soluble keratin 18 released from dying cells and can be used to assess total cell death due to apoptosis and necrosis. The assay is primarily intended to be used together with the M30 Apoptosense® ELISA, which specifically measures apoptosis. When used together, the quantification of total cell death, apoptosis and necrosis is possible. As both assays are calibrated against the identical reference, the combination of M30 Apoptosense® ELISA and M65® ELISA should allow determining the relative contribution of apoptosis to the total degree of cell death. M65® ELISA is intended for human sera, and is CE marked as a medical device for in vitro diagnostic use.

References:

Speak to a Scientist

















What would you like to discuss?

With whom will we be speaking?






I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

Yes I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.


biomarker services

Services

See how our premier bioanalytical services support all phases of biomarker, immunogenicity, PK, and cell-based assay studies.

Explore our services

case studies

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Read our case studies